Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008397
Filing Date
2017-11-07
Accepted
2017-11-07 16:24:35
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ecyt-20170930x10q.htm 10-Q 1729871
2 EX-31.1 ecyt-20170930ex311a0392b.htm EX-31.1 19976
3 EX-31.2 ecyt-20170930ex312044982.htm EX-31.2 18042
4 EX-32.1 ecyt-20170930ex321473202.htm EX-32.1 15477
  Complete submission text file 0001558370-17-008397.txt   6453748

Data Files

Seq Description Document Type Size
5 EX-101.INS ecyt-20170930.xml EX-101.INS 1540433
6 EX-101.SCH ecyt-20170930.xsd EX-101.SCH 33257
7 EX-101.CAL ecyt-20170930_cal.xml EX-101.CAL 32257
8 EX-101.DEF ecyt-20170930_def.xml EX-101.DEF 145442
9 EX-101.LAB ecyt-20170930_lab.xml EX-101.LAB 334566
10 EX-101.PRE ecyt-20170930_pre.xml EX-101.PRE 277256
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 171183693
SIC: 2834 Pharmaceutical Preparations